1. Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
   Elaine C. D. Gonçalves et al, 2020, Molecules CrossRef
2. Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances
   Run-Ze Chen et al, 2021, Frontiers in Oncology CrossRef
3. A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F
   Shao-Ru Chen et al, 2018, Frontiers in Pharmacology CrossRef
4. Small molecule tyrosine kinase inhibitors and pancreatic cancer—Trials and troubles
   Bhaskar Venkata Kameswara Subrahmanya Lakkakula et al, 2019, Seminars in Cancer Biology CrossRef
5. Telomerase and Its Therapeutic Implications in Cancer
   Raman Kumar et al, 2022, Cancer Diagnostics and Therapeutics CrossRef
6. Pristimerin enhances the effect of cisplatin by inhibiting the miR‑23a/Akt/GSK3β signaling pathway and suppressing autophagy in lung cancer cells
   Yingbing Zhang et al, 2019, International Journal of Molecular Medicine CrossRef
7. Fundamental insights into the interaction between telomerase/TERT and intracellular signaling pathways
   Somayyeh Ghareghomi et al, 2021, Biochimie CrossRef
8. Pristimerin in Oxidative Stress and Use in Cancer
   Ana Carolina B. da C. Rodrigues et al, 2021, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
9. Anticancer Potential and Molecular Targets of Pristimerin in Human Malignancies
   Kirti Prabhu et al, 2024, Pharmaceuticals CrossRef
10. Pristimerin Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review
    Jian Sun et al, 2024, Drug Design, Development and Therapy CrossRef
11. Telomerase Inhibitors from Natural Products and Their Anticancer Potential
    Kumar Ganesan et al, 2017, International Journal of Molecular Sciences CrossRef
12. Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review
    Jia-jun Li et al, 2019, Frontiers in Pharmacology CrossRef
13. Therapeutic strategies for targeting telomerase in cancer
    Xing Chen et al, 2020, Medicinal Research Reviews CrossRef
14. Inhibition of hTERT in pancreatic cancer cells by pristimerin involves suppression of epigenetic regulators of gene transcription
    Dorrah Deeb et al, 2017, Oncology Reports CrossRef
15. Targeting telomerase for its advent in cancer therapeutics
    Shalini Bajaj et al, 2020, Medicinal Research Reviews CrossRef
16. The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-art
    YingZheng Wang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
17. Pristimerin in Oxidative Stress and Use in Cancer
    Ana Carolina B. da C. Rodrigues et al, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
18. New N,C-Diaryl-1,2,4-triazol-3-ones: Synthesis and Evaluation as Anticancer Agents
    Dolores Santa María et al, 2019, Medicinal Chemistry CrossRef